Century Therapeutics unveils plans to expand CNTY-101 clinical development into additional autoimmune diseases, including systemic lupus erythematosus. $60 million private placement supports R&D activities. Acquisition of Clade Therapeutics enhances pipeline with iPSC-focused programs.
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session.
TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share.
TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 100 points on Tuesday.
Shares of Hewlett Packard Enterprise Company (NYSE: HPE) shares fell sharply in pre-market trading on Tuesday.
Nkarta, Inc. (NASDAQ: NKTX) shares are blasting higher Monday, and the stock has gained more than 270% over the past month. Here's a look at what's going on.
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Monday.
The Dow traded up 0.35% to 37,596.43 while the NASDAQ rose 1.89% to 14,799.21. The S&P 500 also rose, gaining, 1.11% to 4,749.41.
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates.
Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 60 points on Wednesday.
Shares of Pinstripes (NYSE: PNST) shares fell in pre-market trading after surging 22% on Tuesday.